Financial Statements and Related Announcement::Auditor's Comments of Accounts

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
30-Sep-2026 07:07:09
Status
New
Announcement Sub Title
Auditor's Comments of Accounts
Announcement Reference
SG260930OTHRXBU6
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)

Please refer to the attachment.

Additional Details

For Financial Period Ended
30/06/2026

Attachments

Announcement - Auditors comment on FY2026 final.pdf
Total size =431K